AstraZeneca and Global Transparency

AstraZeneca strongly believes that interactions with HCPs/HCOs positively influence the quality of patient treatment and the value of medical research.

To provide patients with optimal treatment options, HCPs need to stay informed about the latest developments with current and potential new medicines. The pharmaceutical industry has a duty to provide this information.

HCPs in turn provide the industry with insights into how to improve medicines by feeding back on how they work in real world settings.

We also recognize that patients expect transparency around these relationships to feel confident that HCPs are impartial and always recommend the most appropriate the most appropriate treatment options.

We believe that regulations such as US Open Payments, the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure code, and others across the globe, which require companies to disclose payments and transfers of value made to HCPs and HCOs, will provide greater transparency around these already well-regulated relationships.

The payments and transfers of value disclosed here were made for activities such as providing professional advice about how medicines are used in practice, sharing professional expertise at medical education meetings, taking part in advisory boards, research and educational grants.

Europe

To download the assumptions and interpretations of the Disclosure Code for each of our markets, and to download market-level disclosure reports, please click on the links below.

The EFPIA Disclosure Code 2017 Self Certification Letter affirms AstraZeneca’s commitment to the principles of the EFPIA Disclosure Code.


Austria

Belgium

Bulgaria

Croatia

Cyprus

Czech Republic

Denmark

Transparency obligations have been fulfilled per local requirements.  Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.

Estonia

Finland

France

Transparency obligations have been fulfilled per local requirements.  Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.

Germany

Greece

Romania

Transparency obligations have been fulfilled per local requirements.  Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.

Russia

Serbia

Slovakia

Transparency obligations have been fulfilled per local requirements.  Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.

Slovenia

Spain

Sweden

Switzerland

Turkey

Transparency obligations have been fulfilled per local requirements.  Inquiries may be submitted to the Global Payment Transparency team at Global-Payment-Transparency@astrazeneca.com.

Ukraine

United Kingdom



US

For information about US Open Payments, please visit our Physician engagement page or the US Open Payments page managed by the Centers for Medicaid and Medicare Services (CMS).



Asia Pacific


Last updated June 2017